Module 3 biosafety principles & microbiologycal risk group 21 1-18

31 de Aug de 2018
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
1 de 26

Mais conteúdo relacionado

Mais procurados

Bio safety level in laboratory Bio safety level in laboratory
Bio safety level in laboratory Aman Ullah
Lab biosafety and biosecurityLab biosafety and biosecurity
Lab biosafety and biosecurityMajed Mohammed
Laboratory BiosafetyLaboratory Biosafety
Laboratory BiosafetyPhilippine Hospital Infection Contol Nurses Associaton (PHICNA) Inc.
Laboratory Associated InfectionsLaboratory Associated Infections
Laboratory Associated Infections90TrishaR
BIOSAFETY AND BIOSECURITY REGULATORY ENVIRONMENT AND PRACTICES AT SCIENSANO B...BIOSAFETY AND BIOSECURITY REGULATORY ENVIRONMENT AND PRACTICES AT SCIENSANO B...
BIOSAFETY AND BIOSECURITY REGULATORY ENVIRONMENT AND PRACTICES AT SCIENSANO B...European Center for Disease Prevention and Control (ECDC)
Introduction of BiosafetyIntroduction of Biosafety
Introduction of BiosafetyAtifa Ambreen

Mais procurados(20)

Similar a Module 3 biosafety principles & microbiologycal risk group 21 1-18

Laboratory oranization and biosafety requirements of microbiology laboratoryLaboratory oranization and biosafety requirements of microbiology laboratory
Laboratory oranization and biosafety requirements of microbiology laboratoryAuricle Nissim
BIOSAFETY MANAGEMENT.pptBIOSAFETY MANAGEMENT.ppt
BIOSAFETY MANAGEMENT.pptEstherShobhaR
Biosafety and Cartagena ProtocolBiosafety and Cartagena Protocol
Biosafety and Cartagena ProtocolAmrutha Hari
8. principles of biosafety, biocontainment & program management (nbb160)8. principles of biosafety, biocontainment & program management (nbb160)
8. principles of biosafety, biocontainment & program management (nbb160)kckenned
Biosafety levels.pdfBiosafety levels.pdf
Biosafety levels.pdfssuser8f10bd
Biosafety in microbiology laboratoryBiosafety in microbiology laboratory
Biosafety in microbiology laboratoryMicrobiology

Mais de EhealthMoHS

Nccpe report 2017Nccpe report 2017
Nccpe report 2017EhealthMoHS
Myanmar fetp intermediate implementation planMyanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation planEhealthMoHS
Myanmar cdc (14 12-17)Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)EhealthMoHS
MvaMva
MvaEhealthMoHS
Module 6 emergency responseModule 6 emergency response
Module 6 emergency responseEhealthMoHS
Module 5 shipping & transportation of inf materials 21 1-2018Module 5 shipping & transportation of inf materials 21 1-2018
Module 5 shipping & transportation of inf materials 21 1-2018EhealthMoHS

Último

HEMODYNAMICS & NATURAL HISTORY OF PS.pptxHEMODYNAMICS & NATURAL HISTORY OF PS.pptx
HEMODYNAMICS & NATURAL HISTORY OF PS.pptxAparanji Gopidi
Opportunistic gastrointestinal pathogensOpportunistic gastrointestinal pathogens
Opportunistic gastrointestinal pathogensMohammad Sourav Islam
PTC.pptxPTC.pptx
PTC.pptxDr. Dheeraj Kumar
Lesson Plan (Fruit).pdfLesson Plan (Fruit).pdf
Lesson Plan (Fruit).pdfAlvinChan876939
OVERVIEW OF ANTIMICROBIAL STEWARDSHIPOVERVIEW OF ANTIMICROBIAL STEWARDSHIP
OVERVIEW OF ANTIMICROBIAL STEWARDSHIPTanveerRehman4
Catheter and Guidewire.pptxCatheter and Guidewire.pptx
Catheter and Guidewire.pptxDr. Dheeraj Kumar

Module 3 biosafety principles & microbiologycal risk group 21 1-18

Notas do Editor

  1. To know a little bit about biosafety principle & that are risk group of Mibrobiology
  2. The goal of preventing injuries and diseases from occurring among students, scientists, laboratory staff and the community
  3. The term containment describes safe methods for managing infectious materials in the laboratory environment where they are being handled or maintained. The purpose of containment is to reduce or eliminate exposure to potentially hazardous agents. Exposure could involve not only laboratory workers but also other individuals working close by and the outside environment. 
  4. Element containment Primary containment Is the protection of personnel and the immediate laboratory environment from exposure to infectious agents and also provided by both good microbiological technique and the use of appropriate safety equipment. For example, produce vaccines may provide an increased level of personal protection. For the secondary containment Is the protection of the environment external to the laboratory from exposure to infectious materials So the facility design, operational practices. Ventilation systems, controlled access, airlocks, and other facility design features must be part of any biosafety program. 
  5. Knowledge of agent characteristics - virulence and pathogenicity - Experimental procedures and manipulations that influence escape, transmission and exposure Risk assessment to evaluation of hazards and the potential for laboratory-associated disease Sources of assistance National/international guidelines and professional biosafety personnel
  6. Level 1 for agents that are “defined and characterized strains of viable microorganisms not known to consistently cause disease in healthy adult humans.”B. subtilis, E. coli K12, S. cervasiae Containment relies on “standard microbiological practices, no special…barriers other than a sink for hand washing.”
  7. Level 2 for the “broad spectrum of indigenous moderate-risk agents that are present in the community and associated with disease of varying severity.” S. aureus, B. anthracis, HIV, Hep B Containment relies primarily on “good microbiological technique…” provided the potential for producing splashes and aerosols is low. Primary hazard is by accidental percutaneous or mucous membrane exposure. Careful with sharps!!!
  8. This moderate-risk agents that pose a danger if accidentally inhaled, swallowed or exposed to the skin. Safety measures include limited access, biohazard warning signs, sharps precautions, class I or II BSCs The use of PPE such as gloves and eyewear as well as hand washing sinks and waste decontamination facilities such as an autoclave. 
  9. BSL-3 laboratories are used to study agents that work is done with indigenous or exotic agents with a potential for respiratory transmission, and which may cause serious and potentially lethal infection Laboratory personnel must receive specific training and equipment in handling pathogenic agents. Supervision by a competent scientist who is experienced in working with these agents.
  10. Biosafety Level 3, more emphasis is placed on primary and secondary barriers to protect personnel in this areas All laboratory manipulations should be performed in a BSC Personnel wearing appropriate personal protective clothing Secondary barriers for this level include controlled access to the laboratory and ventilation requirements to minimize the release of infectious aerosols from the laboratory Biosafety Level 3 
  11. Biosafety Level 4 should be under the control of national or other appropriate health authorities. Required for working with dangerous and exotic agents that pose a high individual risk of aerosol transmitted laboratory infections and life threatening disease. Which there is no available vaccine or therapy Agents with a close or identical antigenic relationship to Biosafety Level 4 agents also should be handled at this level When sufficient data are obtained, work with these agents may continue at this level or at a lower level The laboratory worker's complete isolation from aerosolized infectious materials is accomplished primarily by working in a Class III BSC or in a full-body, air-supplied positive-pressure personnel suit 
  12. Personnel must receive specialized training in handling extremely dangerous infectious agents, containment equipment and functions All laboratory staff and supervisors must be competent in handling agents and procedures requiring Access to the laboratory is controlled by the laboratory supervisors in accordance with institutional policies Two types of laboratory providing absolute separation of the worker from the infectious agents
  13. The World Health Organization (WHO) developed a Risk Group classification of infective microorganisms handled in laboratories that emphasizes the importance of assessing both individual and community risks. The Risk Group classification describes four risk groups 1, 2, 3 and 4
  14. A pathogen that can cause human or animal disease but is unlikely to be serious hazard to laboratory workers, the community, livestock or the environment. Laboratory exposures may cause serious infection, but effective treatment and preventative measures are available and the risk of spread of infection is limited.
  15. Pathogenic, cause serious disease Effective treatment and preventive measures usually available Little person-to-person spread
  16. pathogenic agent Readily transmittable direct, indirect Effective treatment and preventive measures not usually available
  17. influenced by existing levels of immunity in the local population and movement of the host population, presence of appropriate vectors and standards of environmental hygiene. - prophylaxis by immunization or administration of antisera (passive immunization) - sanitary measures, e.g., food and water hygiene control of animal reservoirs or arthropod vectors Local availability of effective treatment - passive immunization, pot-exposure vaccination and use of antimicrobials, antivirals and chemotherapeutic agents - the possibility of the emergence of drug-resistant strains